7 Cheap But Risky Biotech Stocks

Biotech stocks remain depressed, nearly two years into a dip that has seen the


SPDR S&P Biotech ETF


drop nearly 50%.

The other most-watched exchange-traded fund that tracks the biotech sector, the i


Shares Biotechnology ETF


(ticker: IBB), is down 20% over the same period, since early February of 2021. The


S&P 500


is up just over 2% since then.